Publications by authors named "Mona Bafadhel"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

269

Total Likes

375

Extended Reach

2,161,420

Social Features

166
D
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Jeremy Cole, Mona Bafadhel, Stephanie A Christenson, Alberto Papi, Dave Singh, Elizabeth Laws

July 2023

Videos about Article: user user

2 2 164 5 176

View All Article and Social Media Activity
B
Blood Eosinophil Counts in Healthy Volunteers and in Patients with Asthma and COPD in India: A Multi-Centre Cross-Sectional Report.
Raja Dhar, Sanjay Ramakrishnan, Parvaiz A Koul, Manoranjan Dash, Jyoti Patnaik, Mona Bafadhel

Int J Chron Obstruct Pulmon Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk-Benefit Balance of Oral Corticosteroid Treatment for Asthma Attacks: A Discrete Choice Experiment of Patients and Healthcare Professionals in the UK and New Zealand.
Imran Howell, Jonathan Noble, Aleksandra Howell, Caitlin Morgan, Jennifer Logan, Mona Bafadhel

Respirology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rebranding COPD Care and Research in the 21st Century.
Joan B Soriano, Mona Bafadhel, Christine R Jenkins

Respirology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study.
Imran Howell, Mahdi Mahdi, Hafiz R Mahmood, Laura Bermejo-Sanchez, Catherine Borg, Mona Bafadhel

Eur Respir J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidimensional prognostic risk stratification of COPD exacerbations: the baseline, acuity, and trigger (BAt) model.
Hnin W W Aung, Kristina Vermeersch, Hamish J C McAuley, Sanjay Ramakrishnan, Mustafa Abdo, Mona Bafadhel

Lancet Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells.
Anastasia Polycarpou, Tara Wagner-Gamble, Roseanna Greenlaw, Lauren O'Neill, Varsha Kanabar, Mona Bafadhel

Proc Natl Acad Sci U S A· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A translational view of airway epithelial dysfunction in COPD.
Christopher E Brightling, Mona Bafadhel, MeiLan K Han, Jean-Francois Papon, Klaus F Rabe

Eur Respir Rev· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 inflammation biomarkers and their association with response to dupilumab in COPD (BOREAS): an analysis of a randomised, placebo-controlled, phase 3 trial.
Stephanie A Christenson, Nicola A Hanania, Surya P Bhatt, Mona Bafadhel, Klaus F Rabe

Lancet Respir Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Dupilumab on Health-Related Quality of Life and Respiratory Symptoms in Patients With COPD and Type 2 Inflammation: BOREAS and NOTUS.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel

Chest· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal changes in cardiopulmonary outcomes of adults born extremely prematurely: United Kingdom Oscillation Study.
Allan Jenkinson, Christopher Harris, Mona Bafadhel, Reza Razavi, Theodore Dassios

Pediatr Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Respiratory Clinicians' Views on Offering "Rescue Packs" to Patients Discharged After COPD Exacerbation: Qualitative Interview Study.
Karolina Kuberska, Graham Martin, John R Hurst, Mona Bafadhel

COPD· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
Claus F Vogelmeier, Klaus F Rabe, Surya P Bhatt, Nicola A Hanania, Mona Bafadhel

Respir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial.
Katherine Hickman, Yasir Tarabichi, Andrew P Dickens, Rachel Pullen, Margee Kerr, Mona Bafadhel

Chronic Obstr Pulm Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Frank C Sciurba, Gerard J Criner, Stephanie A Christenson, Fernando J Martinez, Alberto Papi, Mona Bafadhel

N Engl J Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β-agonist: post-hoc analyses of KRONOS.
Dave Singh, Mona Bafadhel, Niki Arya, Jonathan Marshall, Himanshu Parikh

Respir Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab for chronic obstructive pulmonary disease with type 2 inflammation: a pooled analysis of two phase 3, randomised, double-blind, placebo-controlled trials.
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel

Lancet Respir Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Readability and complexity of written information presented to hospitalised patients for trial consent during the COVID-19 pandemic in the UK: a retrospective document analysis.
Ewan Gourlay, Tim Felton, Mona Bafadhel, Christopher E Brightling, Jane C Davies

BMJ Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review and meta-analysis on mortality protection - making a long story short.
Paola Rogliani, Gan Marco Manzetti, Shima Gholamalishahi, Mona Bafadhel, Luigino Calzetta

Expert Rev Respir Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
Surya P Bhatt, Klaus F Rabe, Nicola A Hanania, Claus F Vogelmeier, Mona Bafadhel

Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD.
Gary Tse, Cono Ariti, Mona Bafadhel, Alberto Papi, Victoria Carter

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial.
Sanjay Ramakrishnan, Richard E K Russell, Hafiz R Mahmood, Karolina Krassowska, James Melhorn, Mona Bafadhel

Lancet Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A response to therapy for COPD with dupilumab.
Surya P Bhatt, Klaus F Rabe, Dave Singh, Mona Bafadhel, Claus F Vogelmeier

Lancet Respir Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab for COPD with Elevated Eosinophil Counts. Reply.
Surya P Bhatt, Klaus F Rabe, Mona Bafadhel

N Engl J Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated basophil count is associated with increased risk of endometriosis.
Qian Feng, Nina Shigesi, Jun Guan, Nilufer Rahmioglu, Mona Bafadhel

Reprod Fertil· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding evidence from randomised controlled trials and meta-analyses: a comparative overview.
Mario Cazzola, Daiana Stolz, Mona Bafadhel, Paola Rogliani

Eur Respir J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis